Merck wants to avoid the tariffs on Keytruda, a really high value anti-cancer drug. The tariff on those drugs would make the anti-cancer treatments even more sky-high than they already are. Merck is just lucky that people do not understand that there are other ways to treat cancer. Very effective and cheap ways to do it.